XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Keshtkar Rajabi S, Delpasand F, Nematollahi S, Soleimani M, Rikhtegar E, Abbasi M A. Platelet indices in acute coronary syndrome patients. Journal of Research in Applied and Basic Medical Sciences 2023; 9 (2) :71-79
URL: http://ijrabms.umsu.ac.ir/article-1-230-en.html
Firoozabadi hospital clinical research development unit (FHCRDU), Department of internal medicine, school of medicine, Iran University of Medical Sciences (IUMS), Tehran, Iran , Amin.abbasi1314@gmail.com
Abstract:   (826 Views)
Background & Aims: platelets play crucial role in acute coronary syndromes (ACS). The importance of platelets in the development and spread of acute coronary syndromes (ACS) is well known. Most studies tried to find an association between platelet indices and cardiovascular diseases (CVD) risk factors; however, the results contradict, and despite the relative ease of obtaining the platelet indices, their use in clinical practice is still limited. This study aimed to investigate the relationship between platelet indices and other influencing factors including age, gender, underlying diseases, and fat profile in determining the risk of ACS.
Materials & Methods: From September 2019 to March 2020, a consecutive of 101 patients (76 men and 25 women) admitted to the CCU in firoozabadi hospital, Tehran, Iran, were enrolled in this cross-sectional study. Patients who had a history of platelet disorders, myeloproliferative disorders, thyroid dysfunctions, receiving blood products, cancers and chemotherapy, and patients who had missing Mean platelet volume (MPV) in current or prior admissions were excluded from the study. Patients were divided into the MI and the UA (Unstable Angina) groups. Data were presented as means ± SD and qualitative variables as frequency (percentage) were considered. Statistical analyzes were performed with SPSS software version 20.
Results: The mean age of patients was 62.5 ± 13.16 years. Age, gender, underlying disease, troponin, ejection fraction, HDL, LDL, cholesterol, and triglyceride were assessed in the patients. The mean fasting blood sugar and LDL were significantly different between the two groups of MI and Unstable Angina (UA), in which P-values were 0.001 and 0.02, respectively. Comparing platelet indices, including platelet count, PDW, and MPV in the two groups, indicated a difference in the PDW variable (P-value 0.008).
Conclusion: Platelet count did not show any significant changes or relation with MI and UA patients. MPV was not significantly higher in the MI group than the UA group, but higher MPV values were related to a higher mortality rate. Elevated PDW was significantly correlated with both MI groups and mortality, thus can be used as a prognostic factor.
Full-Text [PDF 312 kb]   (773 Downloads)    
Type of Study: orginal article | Subject: General

References
1. 1) Hassan NA, Kamal El-Ddin TM, Nagib Kafafy TA, Mahran EH. Platelet indices and blood cell ratios in acute coronary syndrome and their predictive values. J Curr Med Res Pract 2020; 5: 57-62. [DOI:10.4103/JCMRP.JCMRP_51_19]
2. 2) Anderson JL, Morrow DA. Acute myocardial infarction. N Engl J Med 2017;376(21): 2053-64. [DOI:10.1056/NEJMra1606915] [PMID]
3. 3) Ege MR, Acıkgoz S, Zorlu A, Sıncer I, Guray Y, Guray U, et al. Mean platelet volume: an important predictor of coronary collateral development. Platelets 2013; 24(3): 200-4. [DOI:10.3109/09537104.2012.675107] [PMID]
4. 4) Khode V, Sindhur J, Kanbur D, Ruikar K, Nallulwar S. Mean platelet volume and other platelet volume indices in patients with stable coronary artery disease and acute myocardial infarction: A case control study. J Cardiovasc Dis Res 2012; 3(4): 272-5. [DOI:10.4103/0975-3583.102694] [PMID] []
5. 5) Yandrapalli S, Nabors C, Goyal A, Aronow WS, Frishman WH. Modifiable risk factors in young adults with first myocardial infarction. J Am Coll Cardiol 2019; 73(5): 573-84. [DOI:10.1016/j.jacc.2018.10.084] [PMID]
6. 6) Weston C, Gavalova L, Whittaker T, Van Leeven R. How the NHS cares for patients with heart attack? Annual Public Report April 2013-March 2014. 2014. [Google Scholar]
7. 7) Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV, Go AS. Population trends in the incidence and outcomes of acute myocardial infarction N Engl J Med 2010;362(23): 2155-65. [DOI:10.1056/NEJMoa0908610] [PMID]
8. 8) Rosselló X, Huo Y, Pocock S, Van de Werf F, Chin CT, Danchin N, et al. Global geographical variations in ST-segment elevation myocardial infarction management and post-discharge mortality. Int J Cardiol 2017 ;245: 27-34. [DOI:10.1016/j.ijcard.2017.07.039] [PMID]
9. 9) Ahmadi A, Soori H, Mehrabi Y, Etemad K, Khaledifar A. Epidemiological pattern of myocardial infarction and modelling risk factors relevant to in-hospital mortality: the first results from the Iranian Myocardial Infarction Registry. Kardiol Pol 2015;73(6): 451-7. [DOI:10.5603/KP.a2014.0230] [PMID]
10. 10) Ndrepepa G, Colleran R, Braun S, Xhepa E, Hieber J, Cassese S, et al. Comparative prognostic value of postprocedural creatine kinase myocardial band and high‐sensitivity troponin T in patients with non‐ST‐segment elevation myocardial infarction undergoing percutaneous coronary intervention. Catheter Cardiovasc Interv 2018 ;91(2): 215-23. [DOI:10.1002/ccd.27105] [PMID]
11. 11) Fan J, Ma J, Xia N, Sun L, Li B, Liu H. Clinical Value of Combined Detection of CK-MB, MYO, cTnI and Plasma NT-proBNP in Diagnosis of Acute Myocardial Infarction. Clin Lab 2017; 63(3): 427. [DOI:10.7754/Clin.Lab.2016.160533] [PMID]
12. 12) Natsukawa T, Maeda N, Fukuda S, Yamaoka M, Fujishima Y, Nagao H, et al. Significant association of serum adiponectin and creatine kinase-MB levels in ST-segment elevation myocardial infarction. J Atheroscler Thromb 2017: 38232. [DOI:10.5551/jat.38232] [PMID] []
13. 13) Kaplan ZS, Jackson SP. The role of platelets in atherothrombosis. Hematology Am Soc Hematol Educ Program 2011;2011(1): 51-61. [DOI:10.1182/asheducation-2011.1.51] [PMID]
14. 14) Brummitt D, Barker H. The determination of a reference range for new platelet parameters produced by the Bayer ADVIATM120 full blood count analyser. Clin Lab Haematol 2000;22(2): 103-7. [DOI:10.1046/j.1365-2257.2000.00285.x] [PMID]
15. 15) Martin JF, Kristensen SD, Mathur A, Grove EL, Choudry FA. The causal role of megakaryocyte-platelet hyperactivity in acute coronary syndromes. Nat Rev Cardiol 2012;9(11): 658-70. [DOI:10.1038/nrcardio.2012.131] [PMID]
16. 16) Sansanayudh N, Anothaisintawee T, Muntham D, McEvoy M, Attia J. Mean platelet volume and coronary artery disease: a systematic review and meta-analysis. Int J Cardiol 2014;175(3): 433-40. [DOI:10.1016/j.ijcard.2014.06.028] [PMID]
17. 17) Zaccardi F, Rocca B, Pitocco D, Tanese L, Rizzi A, Ghirlanda G. Platelet mean volume, distribution width, and count in type 2 diabetes, impaired fasting glucose, and metabolic syndrome: a meta‐analysis. Diabetes/metab Res Rev 2015;31(4): 402-10. [DOI:10.1002/dmrr.2625] [PMID]
18. 18) Dehghani MR, Taghipour-Sani L, Rezaei Y, Rostami R. Diagnostic importance of admission platelet volume indices in patients with acute chest pain suggesting acute coronary syndrome. Indian Heart J 2014;66(6): 622-8 [DOI:10.1016/j.ihj.2014.10.415] [PMID] []
19. 19) Hendra TJ, Oswald GA, Yudkin JS. Increased mean platelet volume after acute myocardial infarction relates to diabetes and to cardiac failure. Diabetes Res Clin Pract 1988; 5: 63-69 [DOI:10.1016/S0168-8227(88)80080-9] [PMID]
20. 20) Boos CJ, Balakrishnan B, Lip GY. The effects of coronary artery disease severity on time-dependent changes in platelet activation indices in stored whole blood. J Thromb Thrombolysis 2008 ;25(2): 135-40. [DOI:10.1007/s11239-007-0034-8] [PMID]
21. 21) Khandekar MM, Khurana AS, Deshmukh SD, Kakrani AL, Katdare AD, Inamdar AK. Platelet volume indices in patients with coronary artery disease and acute myocardial infarction: an Indian scenario. J Clin Pathol 2006; 59: 146-149. [DOI:10.1136/jcp.2004.025387] [PMID] []
22. 22) Alvitigala BY, Azra MAF, Kottahachchi DU, Jayasekera MMPT, Wijesinghe RANK. A study of association between platelet volume indices and ST elevation myocardial infarction. Int J Cardiol Heart Vasc 2018;21: 7-10 [DOI:10.1016/j.ijcha.2018.09.001] [PMID] []
23. 23) Kotecha T, Rakhit RD. Acute coronary syndromes. Clin Med 2016;16 (Suppl6): s43-8. [DOI:10.7861/clinmedicine.16-6-s43] [PMID]
24. 24) Cameron HA, Philips R, Ibbotson RM, Carson PHM. Platelet size in myocardial infarction. Br Med J 1983;287: 449-51 https://doi.org/10.1136/bmj.287.6408.1883 [DOI:10.1136/bmj.287.6390.449]
25. 25) Martin JF, Plumb J, Kilbey RS, Kishk YT Changes in volume and density of platelets in myocardial infarction. Br Med J 1983;287: 456-9. [DOI:10.1136/bmj.287.6390.456] [PMID] []
26. 26) Małyszczak A, Łukawska A, Dyląg I, Lis W, Mysiak A, Kuliczkowski W. Blood Platelet Count at Hospital Admission Impacts Long-Term Mortality in Patients with Acute Coronary Syndrome. Cardiology 2020;145(3): 148-54. [DOI:10.1159/000505640] [PMID]
27. 27) Perl L, Lerman-Shivek H, Rechavia E, Vaduganathan M, Leshem-Lev D, Zemer-Wassercug N, Dadush O, Codner P, Bental T, Battler A, Kornowski R, Lev EI. Response to prasugrel and levels of circulating reticulated platelets in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 2014;18;63(6): 513-7 [DOI:10.1016/j.jacc.2013.07.110] [PMID]
28. 28) Assiri AS, Jamil AM, Mahfouz AA, Mahmoud ZS, Ghallab M. Diagnostic importance of platelet parameters in patients with acute coronary syndrome admitted to a tertiary care hospital in southwest region, Saudi Arabia. J Saudi Heart Assoc 2012;24(1): 17-21. [DOI:10.1016/j.jsha.2011.08.004] [PMID] []
29. 29) Rechciński T, Jasińska A, Foryś J, Krzemińska-Pakuła M, Wierzbowska-Drabik K, Plewka M, Peruga JZ, Kasprzak JD. Prognostic value of platelet indices after acute myocardial infarction treated with primary percutaneous coronary intervention. Cardiol J 2013;20(5): 491-8. [DOI:10.5603/CJ.2013.0134] [PMID]
30. 30) Kowara M, Grodecki K, Huczek Z, Puchta D, Paczwa K, Rymuza B, Zbroński K, Filipiak KJ, Opolski G. Platelet distribution width predicts left ventricular dysfunction in patients with acute coronary syndromes treated with percutaneous coronary intervention. Kardiol Pol 2017;75(1): 42-47. [DOI:10.5603/KP.a2016.0137] [PMID]
31. 31) Ohlow MA, Wong V, Brunelli M, von Korn H, Farah A, Memisevic N, Richter S, Tukhiashvili K, Lauer B. Acute coronary syndrome without critical epicardial coronary disease: prevalence, characteristics, and outcome. Am J Emerg Med 2015;33(2): 150-4. [DOI:10.1016/j.ajem.2014.10.048] [PMID]
32. 32) Cupples LA. Section 34: some risk factors related to the annual incidence of cardiovascular disease and death in pooled repeated biennial measurements. Framingham Heart Study: 30 Year Follow FollUp. 1987: 1-22. [URL]
33. 33) Kaneko H, Itoh H, Kiriyama H, Kamon T, Fujiu K, Morita K, Michihata N, Jo T, Takeda N, Morita H, Yasunaga H. Lipid profile and subsequent cardiovascular disease among young adults aged< 50 years. Am J Cardiol 2021;(1)142: 59-65. [DOI:10.1016/j.amjcard.2020.11.038] [PMID]
34. 34) Kurihara O, Takano M, Yamamoto M, Shirakabe A, Kimata N, Inami T, Kobayashi N, Munakata R, Murakami D, Inami S, Okamatsu K. Impact of prediabetic status on coronary atherosclerosis: a multivessel angioscopic study. Diabetes Care 2013;36(3): 729-33. [DOI:10.2337/dc12-1635] [PMID] []

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Journal of Research in Applied and Basic Medical Sciences

Designed & Developed by : Yektaweb